Patents Assigned to Iterum Therapeutics International Limited
  • Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof
    Patent number: 12128034
    Abstract: The present disclosure relates to combinations of valproic acid or a pharmaceutically acceptable salt thereof, a ?-lactam compound or a pharmaceutically acceptable salt thereof, and probenecid or a pharmaceutically acceptable salt thereof. The present disclosure also relates to methods of treating or preventing a disease using the combinations.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: October 29, 2024
    Assignee: Iterum Therapeutics International Limited
    Inventor: Michael Dunne
  • Combinations of ?-lactam compounds and probenecid and uses thereof
    Patent number: 12109197
    Abstract: The present disclosure relates to combinations of a ?-lactam compound or a pharmaceutically acceptable salt thereof and probenecid or a pharmaceutically acceptable salt thereof. The present disclosure also relates to methods of treating or preventing a disease via administering to subjects in need thereof a ?-lactam compound or a pharmaceutically acceptable salt thereof and probenecid or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 13, 2022
    Date of Patent: October 8, 2024
    Assignee: Iterum Therapeutics International Limited
    Inventor: Michael Dunne
  • Combinations of beta-lactam compounds and probenecid and uses thereof
    Patent number: 11478428
    Abstract: The present disclosure relates to bilayer tablets comprising a second layer comprising a ?-lactam compound or a pharmaceutically acceptable salt thereof; and a first layer comprising probenecid or a pharmaceutically acceptable salt thereof. The present disclosure also relates to methods of treating or preventing a disease using the bilayer tablets.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: October 25, 2022
    Assignee: Iterum Therapeutics International Limited
    Inventors: Michael Dunne, Tom Loughman, Aaron Cameron